ERG and prostate cancer: Of specific interest for prostate cancer molecular mechanisms is the study by Fu et al. [122], who developed immunoprecipitation-MS assays to measure the endogenous TMPRSS2-ERG fusion protein in VCaP prostate cancer cells, even in low abundance and with its isoforms and interactome.